logo

Aclaris Therapeutics (ACRS)



Trade ACRS now with
  Date
  Headline
11/29/2022 7:17:44 AM Aclaris Therapeutics, Pediatrix Therapeutics Announce License Deal For ATI-1777 In Greater China
6/27/2022 7:24:03 AM Aclaris Therapeutics Appoints Gail Cawkwell As Chief Medical Officer
6/8/2021 7:13:13 AM Aclaris Therapeutics Announces Positive Preliminary Topline Data From Phase 2a Trial Of ATI-1777 For Atopic Dermatitis
3/15/2021 7:18:16 AM Aclaris Therapeutics Completes Enrollment In Phase 2a Clinical Trial Of ATI-1777
1/19/2021 7:08:59 AM Aclaris Announces Positive Preliminary Data From 12-Week Phase 2a Trial Of Oral ATI-450 For Rheumatoid Arthritis
9/12/2017 9:54:14 AM William Blair Reiterates Aclaris Therapeutics (ACRS) At Ourperform
3/16/2017 9:10:40 AM William Blair Is Cutting Aclaris Therapeutics (ACRS) FY18 Rev. Estimate To 30.2 M From 55.6 M
3/16/2017 9:10:16 AM William Blair Is Cutting Aclaris Therapeutics (ACRS) FY18 Estimate To -4.10 From -1.20
3/16/2017 9:10:00 AM William Blair Is Lowering Aclaris Therapeutics (ACRS) FY17 Estimate To -3.57 From -3.35